Valuation: Artrya Limited

Market Cap 399M 281M 251M 232M 210M 393M 26.66B 2.79B 1.1B 13.97B 1.05B 1.03B 44.03B P/E 2027 *
-19.7x
P/E 2028 * -31.4x
Enterprise Value 357M 251M 224M 207M 188M 352M 23.86B 2.5B 988M 12.5B 943M 923M 39.41B EV / Sales 2027 *
52.6x
EV / Sales 2028 * 17.8x
Free-Float
80.66%
Yield 2027 *
-
Yield 2028 * -

Last Transcript: Artrya Limited

1 day-7.55%
1 week-5.41%
Current month-31.18%
1 month-35.86%
3 months-54.71%
6 months-41.11%
Current year-47.98%
1 week 2.42
Extreme 2.42
2.82
1 month 2.42
Extreme 2.42
4.2
Current year 2.42
Extreme 2.42
6.49
1 year 2.42
Extreme 2.42
6.49
3 years 0.16
Extreme 0.16
6.49
5 years 0.16
Extreme 0.16
6.49
10 years 0.16
Extreme 0.16
6.49
Manager TitleAgeSince
Chief Executive Officer - 2025-06-30
Director of Finance/CFO - 2026-08-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 72 2021-01-31
Director/Board Member 71 2022-07-31
Director/Board Member 67 2023-02-21
Date Insider Type Main position Quantity % Market Cap. Importance
7/10/26 Expiration

Chairman

-750,000 0.4602%
4/14/26 Exercice

Chairman

500,000 0.3163%
4/14/26 Exercice

Chairman

500,000 0.3163%
Change 5-day change 1-year change 3-year change Capi.($)
-7.55%-5.41%-26.65%+1,189.47% 303M
-1.28%+1.14%+15.22%+35.40% 121B
+1.03%+2.92%+7.29%+96.01% 101B
+0.93%+2.98%+107.78%+910.93% 59.59B
+2.30%+2.61%-6.79%+78.43% 28.59B
-0.74%+2.96%+32.05%+99.23% 26.85B
-0.08%+3.89%+16.31%+66.89% 26.76B
-0.30%+1.18%+30.68%+394.69% 21.79B
-2.46%-5.71%-23.11%-7.94% 19.57B
-1.39%+1.93%+3.21%+81.47% 19.03B
Average -0.95%-0.77%+15.60%+294.46% 42.45B
Weighted average by Cap. -0.07%+0.60%+24.43%+201.00%

Financials

2027 *2028 *
Net sales 6.8M 4.78M 4.27M 3.95M 3.58M 6.69M 454M 47.48M 18.8M 238M 17.95M 17.57M 750M 20.8M 14.63M 13.06M 12.07M 10.94M 20.46M 1.39B 145M 57.5M 728M 54.9M 53.74M 2.29B
Net income -21.91M -15.41M -13.76M -12.71M -11.52M -21.55M -1.46B -153M -60.56M -766M -57.83M -56.6M -2.42B -14.2M -9.98M -8.92M -8.24M -7.46M -13.96M -948M -99.11M -39.24M -497M -37.47M -36.67M -1.57B
Net Debt -41.91M -29.48M -26.32M -24.32M -22.04M -41.23M -2.8B -293M -116M -1.47B -111M -108M -4.62B -28.52M -20.06M -17.91M -16.55M -15M -28.06M -1.9B -199M -78.85M -998M -75.29M -73.69M -3.15B
Projected Income Statement - Annual - Artrya Limited
Logo Artrya Limited
Artrya Limited is a medical technology company. The Company is engaged in development and commercialization of its patented artificial intelligence (AI) platform that detects, diagnoses, and helps address coronary artery. It partners with clinics receiving chest pain patients to deliver new models of cardiovascular care based on AI. Easily integrate plaque features of high prognostic value into the evaluation of coronary artery disease. Its Artrya Salix is a computed tomography coronary angiography (CCTA) image analysis solution that enables physicians with AI to identify and analyze the extent and type of arterial plaque. This solution uses no external reading teams to validate cardiac scan data, allowing physicians direct control of their AI-supported patient scans. Its Artrya Salix assists physicians in the rapid and convenient analysis of cardiac CT scans to screen patients at risk of heart attack.
Employees
-
Date Price Change Volume
26-10-23 A$2.450 -7.55% 1,180,256
26-10-22 A$2.650 0.00% 513,999
26-10-21 A$2.650 +4.33% 1,105,749
26-10-20 A$2.540 -3.79% 1,748,516
26-10-19 A$2.640 -3.65% 1,324,147
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
MarketScreener Ratings - Artrya Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.450AUD
Average target price
6.242AUD
Spread / Average Target
+154.80%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Artrya Limited